CureVac’s COVID-19 vaccine (CVnCoV) (COVID-19 mRNA vaccine)
- Region
- 🇪🇺 EU
- Active substance
- COVID-19 mRNA vaccine
- Company
- CureVac AG
- Status
- Withdrawn from rolling review
- Application
- EMEA/H/C/005845
- ATC
- J07BX03
- Official record
- www.ema.europa.eu
Indication
COVID-19 Vaccine
Regulatory milestones
No milestones recorded in the last year.
Same substance in other markets
- 🇪🇺 Comirnaty Authorised · BioNTech Manufacturing GmbH
- 🇪🇺 Spikevax (previously COVID-19 Vaccine Moderna) Authorised · Moderna Biotech Spain, S.L.
- 🇪🇺 mNexspike Authorised · Moderna Biotech Spain, S.L.
- 🇪🇺 mCombriax Authorised · Moderna Biotech Spain, S.L.
Follow CureVac’s COVID-19 vaccine (CVnCoV)
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.